MedTrace Logo

Analysis of Intestinal Defensin Expression in Acute GVHD

NCT04522843 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2024-12-18

No results posted yet for this study

Summary

This study has the aim to analyze intestinal expression of endogenous antimicrobial peptides in patients with acute GVHD. The expression will be compared to intestinal expression of defensins in patients with colitis and patients without intestinal inflammation.

Conditions

Sponsors & Collaborators

  • University of Freiburg

    lead OTHER

Principal Investigators

  • Robert Zeiser, Prof. Dr. · Medical Center University of Freiburg

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2024-10-30
Completion
2024-10-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04522843 on ClinicalTrials.gov